We are live on ! Find out more
NEPH icon

Nephros
NEPH

18 hedge funds and large institutions have $15.1M invested in Nephros in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

138% more capital invested

Capital invested by funds: $6.35M → $15.1M (+$8.76M)

29% more funds holding

Funds holding: 14 → 18 (+4)

0.73% more ownership

Funds ownership: 40.89% → 41.62% (+0.73%)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
6
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$114K
2
MFIM
Mesirow Financial Investment Management
Illinois
+$33.5K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$25.6K
4
GIP
Granite Investment Partners
California
+$24.4K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.94K

Top Sellers

Rank Fund Capital Flow
1
EP
Elkhorn Partners
Nebraska
-$29.3K
2
WC
Wexford Capital
Florida
-$10.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
1
Wexford Capital
Florida
$12.7M -$10.3K -4,714 -0.1%
BA
2
Bard Associates
Illinois
$648K +$2.78K +1,279 +0.7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$593K +$1.3K +598 +0.4%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$245K – – –
Morgan Stanley
5
Morgan Stanley
New York
$234K +$114K +52,256 +342%
HighTower Advisors
6
HighTower Advisors
Illinois
$196K – – –
William Blair & Company
7
William Blair & Company
Illinois
$125K – – –
EP
8
Elkhorn Partners
Nebraska
$110K -$29.3K -13,441 -30%
State Street
9
State Street
Massachusetts
$54.2K – – –
MFIM
10
Mesirow Financial Investment Management
Illinois
$53.2K +$33.5K +15,383 New
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$40.7K +$25.6K +11,784 New
GIP
12
Granite Investment Partners
California
$38.8K +$24.4K +11,220 New
BlackRock
13
BlackRock
New York
$14.3K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$8.63K +$4.94K +2,268 +1,004%
Wells Fargo
15
Wells Fargo
California
$249 +$9 +4 +6%
UBS Group
16
UBS Group
Switzerland
$38 – – –
JP Morgan Chase
17
JP Morgan Chase
New York
$35 +$4 +2 +25%
Bank of America
18
Bank of America
North Carolina
$28 +$17 +8 New

NEPH Hedge Fund Activity: Q4 2023 in Review

18 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q4 2023, worth a combined $15.1M — up 138% from $6.35M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NEPH positions and 0 closed out — a net gain of 4 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $114K. The largest seller was Elkhorn Partners, cutting an estimated $29.3K.

  • 18 institutional investors held Nephros (NEPH) as of Q4 2023, up from 14 in Q3 2023.
  • Funds reported $15.1M of Nephros stock for Q4 2023, up 138% quarter-over-quarter.
  • 4 funds opened new Nephros positions in Q4 2023 and 0 closed out, a net change of +4 holders.
  • The largest Nephros buyer in Q4 2023 was Morgan Stanley, an estimated $114K added.
  • The largest Nephros seller in Q4 2023 was Elkhorn Partners, an estimated $29.3K sold.

Based on aggregated 13F filings for Q4 2023.